EUVIMEDEUVIMED entdecken
Crossref

Multi-nanocarrier Strategy for Light-Activated Nitric Oxide Release: Ruthenium Nitrosyl Complexes in Liposomes, Micelles, and Niosomes for Cancer Therapy

Nitin, Nancy Sharma iD, Priyanka Sharma, Vinod Kumar, Asifkhan Shanavas iD, D Amilan Jose iD

ACS Applied Bio Materials · 17.11.2025 · 8 (11) · 10078-10089

DOI: 10.1021/acsabm.5c01415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 27.10.2025. Verfasst von Nitin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology Kurukshetra, Kurukshetra, 136119 Haryana, India. Hauptthemen laut MEDLINE: Nitric Oxide, Ruthenium, Antineoplastic Agents, Biocompatible Materials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board, Haryana State Council for Science Innovation and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitric oxide (NO), once regarded solely as an atmospheric pollutant, is now widely recognized for its important therapeutic functions in biological systems. However, several challenges limit its direct medical use, such as its short half-life, the non-biocompatibility of several NO donors, and their uncontrolled release patterns. To address these challenges, a series of nanomaterials, including vesicles, micelles, and niosomes, have been developed to incorporate a newly synthesized amphiphilic ruthenium nitrosyl (Ru-NO) complex as a versatile photoactivatable NO donor. Notably, this is the first report of encapsulating this amphiphilic Ru-NO complex designated as 1·NO, in niosomes (termed 1·NO-Nio) for phototriggered NO delivery. The release kinetics and quantum yield of 1·NO, as well as its nanoencapsulated forms 1·NO-Ves, 1·NO-Mic, and 1·NO-Nio, were evaluated using UV–vis spectroscopy, Griess assay, and 4-amino-5-methylamino-2′,7′-difluorescein diacetate (DAF-FM DA) fluorescence under blue light irradiation (420 nm). Free 1·NO released a significant amount of NO (11 μM), whereas encapsulation within nanocarriers resulted in a more controlled and prolonged NO release, with release rates (kNO) of 0.0093, 0.0065, and 0.0025 min–1 for 1·NO-Ves, 1·NO-Mic, and 1·NO-Nio, respectively. All three nanocarrier-based nitric oxide (NO) delivery systems demonstrated pronounced, light-activated anticancer activity in vitro tests against the 4T1 breast cancer cell line, with the liposome-based formulation (1·NO-Ves) exhibiting the strongest therapeutic efficacy. These results underscore how distinct nanomaterial platforms can have a significant influence on the nitric oxide (NO) release behavior of a photocontrollable ruthenium nitrosyl (Ru-NO) complex. This underlines the critical role of nanocarrier design in optimizing the performance of photoactivated NO donors for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideRutheniumAntineoplastic AgentsBiocompatible MaterialsNitric Oxide DonorsDrug CarriersCoordination ComplexesLiposomesMicellesHumansLightDrug Screening Assays, AntitumorParticle SizeMaterials TestingCell ProliferationCell Line, TumorCell SurvivalDrug LiberationSurface Properties

Stichwörter der Autor:innen

biocompatibilityliposomesmicellesniosomesnitric oxide deliveryruthenium nitrosyl complexvesicles

Substanzen

Nitric OxideLiposomesMicellesRutheniumAntineoplastic AgentsBiocompatible MaterialsNitric Oxide DonorsDrug CarriersCoordination Complexes

Autor:innen und Institutionen

  • Department of Chemistry, National Institute of Technology Kurukshetra, Kurukshetra, 136119 Haryana, India.
  • Chemical Biology Unit, Institute of Nano Science and Technology (INST), Knowledge City, Sector 81, Mohali, Punjab 140306, India.

ORCID-Profile: Nancy Sharma, Asifkhan Shanavas, D Amilan Jose

Förderung

  • Council of Scientific and Industrial Research, India
  • Science and Engineering Research Board
  • Haryana State Council for Science Innovation and Technology

Zitieren

APA

Nitin, Sharma, N., Sharma, P., Kumar, V., Shanavas, A., & Jose, D. A. (2025). Multi-nanocarrier Strategy for Light-Activated Nitric Oxide Release: Ruthenium Nitrosyl Complexes in Liposomes, Micelles, and Niosomes for Cancer Therapy. ACS Applied Bio Materials, 8(11), 10078-10089. https://doi.org/10.1021/acsabm.5c01415

Vancouver

Nitin, Sharma N, Sharma P, Kumar V, Shanavas A, Jose DA. Multi-nanocarrier Strategy for Light-Activated Nitric Oxide Release: Ruthenium Nitrosyl Complexes in Liposomes, Micelles, and Niosomes for Cancer Therapy. ACS Applied Bio Materials. 2025;8(11):10078-10089. doi:10.1021/acsabm.5c01415

BibTeX
@article{Nitin2025,
  author = {Nitin and Sharma, Nancy and Sharma, Priyanka and Kumar, Vinod and Shanavas, Asifkhan and Jose, D Amilan},
  title = {Multi-nanocarrier Strategy for Light-Activated Nitric Oxide Release: Ruthenium Nitrosyl Complexes in Liposomes, Micelles, and Niosomes for Cancer Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  volume = {8},
  number = {11},
  pages = {10078--10089},
  doi = {10.1021/acsabm.5c01415}
}
Kostenlos starten →